Therapeutic Drug Monitoring of Direct Oral Anticoagulants May Increase Their Benefit-Risk Ratio.
J Cardiovasc Pharmacol
; 76(4): 472-477, 2020 10.
Article
in En
| MEDLINE
| ID: mdl-33030858
Full text:
1
Database:
MEDLINE
Main subject:
Thrombosis
/
Blood Coagulation
/
Antithrombins
/
Drug Monitoring
/
Factor Xa Inhibitors
/
Rivaroxaban
/
Dabigatran
Type of study:
Diagnostic_studies
/
Etiology_studies
/
Guideline
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Year:
2020
Type:
Article